315 results
Page 5 of 16
8-K/A
EX-99.2
zmylxbn
19 Sep 19
Special Purpose Combined Statements of Revenues and Direct Expenses
9:26pm
D
qdsxwl8x
26 Jul 19
$27M in equity / options / securities to be acquired, sold $14M, 1 investor
8:15pm
8-K
EX-10.2
p8a1f07
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-2.1
ksy 604cny8jysrpjtw7
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-10.1
obwng 2xmyzh3sied9
19 Jul 19
Interpace Diagnostics Acquires Cancer Genetics’ Biopharma Services Business Supported by Investment from Ampersand Capital Partners
5:03pm
8-K
EX-1.1
1z11t tdf2
28 Jan 19
Interpace Diagnostics Announces Proposed Public Offering of Common Stock
9:40pm
424B5
zb1t3bynteo
28 Jan 19
Prospectus supplement for primary offering
5:29pm
424B5
ugem7lmj 3bak2pz3x86
24 Jan 19
Prospectus supplement for primary offering
9:51pm